Join to View Full Profile
8081 Innovation Park DrLevel 4 - Skyline ClinicFairfax, VA 22031
Phone+1 571-472-1390
Fax+1 571-472-1391
Dr. Shafer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
Loyola University Medical CenterResidency, Internal Medicine, 1999 - 2003
Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 1999
Certifications & Licensure
VA State License 2013 - 2026
IL State License 1999 - 2014
PA State License 2003 - 2008
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma
- Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer Start of enrollment: 2012 Jun 01
- Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Jul 08
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsA phase I study of MLN4924 and belinostat in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome.Keri R Maher, Danielle Shafer, Dale Schaar, Dipankar Bandyopadhyay, Xiaoyan Deng
Cancer Chemotherapy and Pharmacology. 2025-01-17 - 12 citationsPhase 1 study of belinostat and adavosertib in patients with relapsed or refractory myeloid malignancies.Danielle Shafer, Amanda B Kagan, Michelle A Rudek, Maciej Kmieciak, Mary Beth Tombes
Cancer Chemotherapy and Pharmacology. 2023-03-01 - 1 citationsIdentification of a Cryptic t(8;20;21)(q22;p13;q22) Resulting in RUNX1T1/RUNX1 Fusion in a Patient with Newly Diagnosed Acute Myeloid Leukemia.Erica L. Macke, Reid G. Meyer, Nicole L. Hoppman, Rhett P. Ketterling, Patricia T. Greipp
Laboratory Medicine. 2021-11-17
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
